Have a personal or library account? Click to login

Showing 1-12 of 23 for the term ""Ocvirk, Janja""

Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib
Article

Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib

Gavric, Ana Ursula, Ocvirk, Janja, Mekjavic, Polona Jaki
Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients
Article

Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients

Rebersek, Martina, Mesti, Tanja, Boc, Marko, Ocvirk, Janja
Paratesticular adenocarcinoma: unusual presentation of metastasis of pancreatic cancer
Article

Paratesticular adenocarcinoma: unusual presentation of metastasis of pancreatic cancer

Ocvirk, Janja, Šeruga, Boštjan
Management of cetuximab-induced skin toxicity with the prophylactic use of topical vitamin K1 cream
Article

Management of cetuximab-induced skin toxicity with the prophylactic use of topical vitamin K1 cream

Ocvirk, Janja
Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma
Article

Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma

Moltara, Maja Ebert, Novakovic, Srdjan, Boc, Marko, Bucic, Marina, Rebersek, Martina, Zadnik, Vesna, Ocvirk, Janja
Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
Article

Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience

Mesti, Tanja, Ebert Moltara, Maja, Boc, Marko, Rebersek, Martina, Ocvirk, Janja
Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells
Article

Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells

Mesti, Tanja, Bouchemal, Nadia, Banissi, Claire, Triba, Mohamed N., Marbeuf-Gueye, Carole, Cemazar, Maja, Moyec, Laurence Le, Carpentier, Antoine F., Savarin, Philippe, Ocvirk, Janja
The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer
Article

The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer

Oblak, Irena, Velenik, Vaneja, Anderluh, Franc, Mozina, Barbara, Ocvirk, Janja
Advances in the treatment of metastatic colorectal carcinoma
Article

Advances in the treatment of metastatic colorectal carcinoma

Ocvirk, Janja
Prognostic factors for overall survival and safety of trans-arterial chemoembolization (TACE) with irinotecan-loaded drug-eluting beads (DEBIRI) in patients with colorectal liver metastases
Article

Prognostic factors for overall survival and safety of trans-arterial chemoembolization (TACE) with irinotecan-loaded drug-eluting beads (DEBIRI) in patients with colorectal liver metastases

Sljivic, Maja, Sever, Masa, Ocvirk, Janja, Mesti, Tanja, Brecelj, Erik, Popovic, Peter
The five-year KRAS, NRAS and BRAF analysis results and treatment patterns in daily clinical practice in Slovenia in 1st line treatment of metastatic colorectal (mCRC) patients with RAS wild-type tumour (wtRAS) – a real- life data report 2013–2018
Article

The five-year KRAS, NRAS and BRAF analysis results and treatment patterns in daily clinical practice in Slovenia in 1st line treatment of metastatic colorectal (mCRC) patients with RAS wild-type tumour (wtRAS) – a real- life data report 2013–2018

Mesti, Tanja, Rebersek, Martina, Ocvirk, Janja
Malignant gliomas: old and new systemic treatment approaches
Article

Malignant gliomas: old and new systemic treatment approaches

Mesti, Tanja, Ocvirk, Janja